BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38578213)

  • 1. CD3+ and CD8+ T cell-based immune cell score as a prognostic factor in clear-cell renal cell carcinoma.
    Åkerla J; Helminen O; Väyrynen JP; Parkkinen A; Järvenpää H; Böhm J; Ahtiainen M; Seikkula H
    Acta Oncol; 2024 Mar; 63():105-110. PubMed ID: 38578213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic effect of immunoscore in patients with clear cell renal cell carcinoma: preliminary results.
    Selvi I; Demirci U; Bozdogan N; Basar H
    Int Urol Nephrol; 2020 Jan; 52(1):21-34. PubMed ID: 31541404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study.
    Alwers E; Kather JN; Kloor M; Brobeil A; Tagscherer KE; Roth W; Echle A; Amitay EL; Chang-Claude J; Brenner H; Hoffmeister M
    J Pathol Clin Res; 2023 Mar; 9(2):129-136. PubMed ID: 36424650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abundant CD8+ tumor infiltrating lymphocytes and beta-2-microglobulin are associated with better outcome and response to interleukin-2 therapy in advanced stage clear cell renal cell carcinoma.
    Davis D; Tretiakova MS; Kizzar C; Woltjer R; Krajbich V; Tykodi SS; Lanciault C; Andeen NK
    Ann Diagn Pathol; 2020 Aug; 47():151537. PubMed ID: 32454441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases.
    Wang Y; Lin HC; Huang MY; Shao Q; Wang ZQ; Wang FH; Yuan YF; Li BK; Wang DS; Ding PR; Chen G; Wu XJ; Lu ZH; Li LR; Pan ZZ; Sun P; Yan SM; Wan DS; Xu RH; Li YH
    Cancer Immunol Immunother; 2018 Mar; 67(3):435-444. PubMed ID: 29204700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.
    Kwak Y; Koh J; Kim DW; Kang SB; Kim WH; Lee HS
    Oncotarget; 2016 Dec; 7(49):81778-81790. PubMed ID: 27835889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
    Pagès F; Mlecnik B; Marliot F; Bindea G; Ou FS; Bifulco C; Lugli A; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Angelova M; Vasaturo A; Maby P; Church SE; Angell HK; Lafontaine L; Bruni D; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Meyers JP; Paustian C; Feng Z; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Sargent DJ; Fox BA; Galon J
    Lancet; 2018 May; 391(10135):2128-2139. PubMed ID: 29754777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Role of the Immunoscore for Patients with Urothelial Carcinoma of the Bladder Who Underwent Radical Cystectomy.
    Li XD; Huang CW; Liu ZF; Jiang LJ; Chen JW; Xie D; Zhou FJ; Lu HM; Liu ZW
    Ann Surg Oncol; 2019 Nov; 26(12):4148-4156. PubMed ID: 31376036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Immunoscore in Colorectal Carcinomas.
    Imen H; Amira H; Fatma K; Raja J; Mariem S; Haithem Z; Ehsene BB; Aschraf C
    Int J Surg Pathol; 2024 Feb; 32(1):58-65. PubMed ID: 37097904
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical significance of prognostic nutritional index (PNI)-monocyte-to-lymphocyte ratio (MLR)-platelet (PLT) score on postoperative outcomes in non-metastatic clear cell renal cell carcinoma.
    Ren W; Zhang H; Cheng L; Zhang Y; Yang C; Nie L; Yang C; Yao P; Han J; Zhuo D
    BMC Surg; 2023 May; 23(1):117. PubMed ID: 37165423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma.
    Chen SH; Xu LY; Wu YP; Ke ZB; Huang P; Lin F; Li XD; Xue XY; Wei Y; Zheng QS; Xu N
    BMC Cancer; 2021 Jan; 21(1):79. PubMed ID: 33468079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
    Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
    Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of various immune cells and Immunoscore in triple-negative breast cancer.
    Ren X; Song Y; Pang J; Chen L; Zhou L; Liang Z; Wu H
    Front Immunol; 2023; 14():1137561. PubMed ID: 37090736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma.
    Zhang XM; Song LJ; Shen J; Yue H; Han YQ; Yang CL; Liu SY; Deng JW; Jiang Y; Fu GH; Shen WW
    Hum Pathol; 2018 Dec; 82():104-112. PubMed ID: 30036594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an independent immune-genes prognostic index for renal cell carcinoma.
    Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C
    BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J
    J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
    Kawakami F; Sircar K; Rodriguez-Canales J; Fellman BM; Urbauer DL; Tamboli P; Tannir NM; Jonasch E; Wistuba II; Wood CG; Karam JA
    Cancer; 2017 Dec; 123(24):4823-4831. PubMed ID: 28832979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.